(Press-News.org) Psoriasis is a chronic disease that causes patients to develop patches of dry, scaly, and itchy skin. It is an autoimmune disorder, which means that it arises from a person's immune system inappropriately targeting that person's own healthy body parts. It is a deeply unpleasant condition, and patients commonly take various medications so that they can live their lives more comfortably.
Professor Min Chen of the Chinese Academy of Medical Sciences and the Peking Union Medical College has conducted extensive research on psoriasis. "There are many patients with psoriasis who also have cardiovascular diseases, such as hypertension, diabetes, hyperlipidemia, and coronary heart disease," she notes. The presence of such cardiovascular diseases is an important consideration when treating patients with psoriasis because, as Prof. Chen explains, "Some of the drugs for psoriasis may increase the risks of these diseases, while some can reduce them." Now, in a recent review article published in Chinese Medical Journal, Prof. Chen and her colleagues provide a summary of the existing scholarly knowledge concerning the associations between the different treatments for psoriasis and risks of cardiovascular diseases.
The authors explore how various drugs influence the long-term risks of what is known as "MACE," an acronym that encompasses myocardial infarction (i.e., heart attack), cerebrovascular accidents (i.e., strokes and similar events), and cardiovascular mortality. They note that some psoriasis treatments, such as tumor necrosis factor-α (TNF-α) inhibitors and methotrexate may actually reduce long-term MACE risk. Conversely, they also note that some interleukin (IL) inhibitors may increase MACE risk. For example, the IL-12/23 inhibitor briakinumab increased MACE risks so much across multiple studies that investigators had to suspend all clinical trials. However, other IL inhibitors such as tildrakizumab and guselkumab do not appear to increase MACE risks. The widely used immunosuppressant cyclosporine A can cause damage to heart muscle tissues. Ultimately, these findings indicate that more research is needed before scientists can rank psoriasis treatments in terms of their effects on long-term MACE risks.
There is currently no consensus among medical scientists on whether systemic treatments for psoriasis can mitigate or worsen arterial plaques, vascular function, and vascular inflammation. There is some evidence that treatments for psoriasis counter inflammation of coronary tissues and can lessen the coronary plaque burdens that contribute to coronary artery disease. Conversely, it has also been found that treatment with TNF-α inhibitors may contribute to an undesirable thickening of the carotid arteries, which are found in the neck and provide blood to the head. Scientists do not yet know whether methotrexate, IL-17 inhibitors, and IL-12/23 inhibitors also have any effect on arterial wall thicknesses.
In addition to the heightened risk of cardiovascular diseases, patients with psoriasis are at an increased risk of developing various risk factors for cardiovascular diseases. These risk factors include obesity, diabetes mellitus, and high blood lipid levels, and the existing literature points to several varied relationships between psoriasis treatment options and risk factors for cardiovascular disease. For example, TNF-α inhibitors may contribute to increased body weight, but IL-17 and IL-12/23 inhibitors may help patients lose weight. Cyclosporine A can increase the risk of diabetes, worsen hypertension, and contribute to unhealthy lipid metabolism profiles.
In conclusion, different psoriasis treatments have different effects on cardiovascular diseases and their risk factors, necessitating a more thorough consideration of each patient's clinical situation before picking a treatment. For example, TNF-α inhibitors and methotrexate are good therapeutic options for patients with psoriasis who are at high risk of experiencing MACE, and inhibitors of IL-17 and IL-12/23 may be beneficial for patients who have arterial plaques.
Prof. Chen expresses hope that these findings will help medical practitioners offer "sound medication advice for patients with psoriasis and cardiovascular complications."
INFORMATION:
Reference
Title of original paper: Association between the systemic treatment of psoriasis and cardiovascular risk
Journal: Chinese Medical Journal
DOI: 10.1097/CM9.0000000000001249
One of the biggest longitudinal research studies of its kind in the world led by The Hospital for Sick Children (SickKids) and the Centre for Addiction and Mental Health (CAMH) suggests that positive outcomes for children with autism spectrum disorder (ASD) are more common than previously thought.
ASD refers to a group of neurodevelopmental conditions resulting in challenges related to communication, social understanding and behaviour. One in 100 people may have ASD and although a person can be diagnosed at any time, ASD symptoms generally appear and are diagnosed in the first few years ...
PRINCETON--Slanted media outlets are often blamed for growing polarization, but new research points to another consequence of consuming partisan news: an erosion of trust in the media.
A team of researchers combined computational social science techniques and experimentation to study the long-term effects of online partisan media on political opinions and trust.
Internet users were asked to change their default browser homepages to either the Huffington Post, a left-leaning news site, or Fox News, a more conservative outlet, during the 2018 U.S. midterm elections. As participants went about their daily activities, they allowed the researchers to survey them multiple times ...
LA JOLLA, CA--A team led by scientists at Scripps Research has made a discovery suggesting that experimental antibody therapies for Parkinson's and Alzheimer's have an unintended adverse effect--brain inflammation--that may have to be countered if these treatments are to work as intended.
Experimental antibody treatments for Parkinson's target abnormal clumps of the protein alpha-synuclein, while experimental antibody treatments for Alzheimer's target abnormal clumps of amyloid beta protein. Despite promising results in mice, these potential treatments so far have not seen much success in clinical trials.
"Our findings provide a possible explanation for why antibody treatments have not yet succeeded ...
KANSAS CITY, MO--Since the beginning of the pandemic, a loss of smell has emerged as one of the telltale signs of COVID-19. Though most people regain their sense of smell within a matter of weeks, others can find that familiar odors become distorted. Coffee smells like gasoline; roses smell like cigarettes; fresh bread smells like rancid meat.
This odd phenomenon is not just disconcerting. It also represents the disruption of the ancient olfactory circuitry that has helped to ensure the survival of our species and others by signaling when a reward (caffeine!) or a punishment (food poisoning!) is imminent.
Scientists ...
Dwindling water supplies and a growing population will halve per capita water use in Jordan by the end of this century. Without intervention, few households in the arid nation will have access to even 40 liters (10.5 gallons) of piped water per person per day.
Low-income neighborhoods will be the hardest hit, with 91 percent of households receiving less than 40 liters daily for 11 consecutive months per year by 2100.
Those are among the sobering predictions of a peer-reviewed paper by an international team of 17 researchers published March 29 in Proceedings of the National Academy of Sciences.
Jordan's deepening water crisis offers a glimpse of challenges ...
Materials such as gallium arsenide are extremely important for the production of electronic devices. As supplies of it are limited, or they can present health and environmental hazards, specialists are looking for alternative materials. So-called conjugated polymers are candidates. These organic macromolecules have semi-conductor properties, i.e. they can conduct electricity under certain conditions. One possible way of producing them in the desired two-dimensional - i.e. extremely flat - form is presented by surface chemistry, a field of research established in 2007.
Since then, many reactions have been developed and interesting materials produced for possible applications. ...
When humans look out at a visual landscape like a sunset or a beautiful overlook, we experience something -- we have a conscious awareness of what that scene looks like. This awareness of the visual world around us is central to our everyday existence, but are humans the only species that experiences the world consciously? Or do other non-human animals have the same sort of conscious experience we do?
Scientists and philosophers have asked versions of this question for millennia, yet finding answers -- or even appropriate ways to ask the question -- has proved elusive. But a team of Yale researchers recently devised an ingenious way to try to solve ...
One specific protein may be a master regulator for changing how cancer cells consume nutrients from their environments, preventing cell death and increasing the likelihood the cancer could spread, a study from the University of Notre Dame has shown.
The study, published in Cell Reports, was completed in the laboratory of Zachary Schafer, the Coleman Foundation Associate Professor of Cancer Biology in the Department of Biological Sciences.
Schafer and collaborators found a protein called SGK1, known to be activated in a variety of cancer cell types, signals the ...
LOS ALAMOS, N.M., March 29, 2021--A first-of-its-kind instrument that samples smoke from megafires and scans humidity will help researchers better understand the scale and long-term impact of fires--specifically how far and high the smoke will travel; when and where it will rain; and whether the wet smoke will warm the climate by absorbing sunlight.
"Smoke containing soot and other toxic particles from megafires can travel thousands of kilometers at high altitudes where winds are fast and air is dry," said Manvendra Dubey, a Los Alamos National Laboratory atmospheric scientist and co-author on a paper published last week in Aerosol Science and Technology. "These smoke-filled clouds can absorb ...
Among patients who return to work after a heart attack, those who work more than 55 hours per week, compared to those working an average full-time job of 35-40 hours a week, increase their odds of having a second heart attack by about twofold, according to a prospective cohort study published today in the Journal of the American College of Cardiology.
Data from the International Labour Office estimates 1 in 5 workers worldwide work over 48 hours per week. Previous studies have found an association between working long hours and increased risk of coronary heart disease and stroke. This is the first study of its kind to examine the effect of long working hours and the risk of a second cardiovascular event ...
